# Individual Patient Expanded Access to CA102N

> **NCT05274204** · — · TEMPORARILY_NOT_AVAILABLE · sponsor: **Holy Stone Healthcare Co., Ltd**

## Conditions studied

- Advanced or Metastatic Colorectal Cancer (mCRC)

## Interventions

- **DRUG:** CA102N

## Key facts

- **NCT ID:** NCT05274204
- **Lead sponsor:** Holy Stone Healthcare Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** TEMPORARILY_NOT_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2023-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05274204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05274204, "Individual Patient Expanded Access to CA102N". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05274204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*